{
    "title": "Deadly brain infection in German MS patient prompts Roche investigation",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4549568/Deadly-brain-infection-German-MS-patient-prompts-Roche-investigation.html",
    "date": "2017-05-28",
    "keywords": [
        "roche",
        "ocrevus",
        "pml",
        "case",
        "patient",
        "biogen",
        "brain",
        "medication",
        "tysabri",
        "disease",
        "drug",
        "risk",
        "statement",
        "information",
        "safety",
        "john",
        "virus",
        "use",
        "reporting",
        "zurich",
        "person",
        "germany",
        "sclerosis",
        "infection",
        "year",
        "drugmaker",
        "wednesday",
        "leukoencephalopathy",
        "incs",
        "dose",
        "source",
        "illness",
        "ms",
        "immune",
        "system",
        "march",
        "disabling",
        "carryover",
        "natalizumab",
        "physician",
        "mention",
        "connection",
        "spokesman",
        "matt",
        "fearer",
        "type",
        "occurrence",
        "management",
        "part",
        "strategy",
        "revenue",
        "blockbuster",
        "cancer",
        "avastin",
        "herceptin",
        "priority",
        "history",
        "share",
        "healthcare",
        "health",
        "cunningham",
        "treatment",
        "decade",
        "return",
        "company",
        "miller",
        "bill",
        "berkrot",
        "york",
        "editing",
        "greg",
        "mahlich",
        "lisa",
        "shumaker"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}